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Staphylococcus  aureus  ( S.  aureus )  is  a  ubiquitous  bacterial  infectious  agent  that  is  becoming  an  
increasingly  problematic  threat  in  hospitals  and  other  patient  care  environments.  In  cystic  
fibrosis  patients,  abnormally  viscous  mucus  prevents  debris  from  being  successfully  cleared  
from  the  lungs,  creating  a  favorable  environment  for  most  S.  aureus  strains.  Efforts  to  build  a  
model  of   unique  lung  infection  sites  are  underway,  but  utilizing  such  a  model  requires  a  robust  
understanding  of  S.  aureus  virulence  factors.  This  study  explored  the  variation  in  virulence  factor  
expression  among  S.  aureus  clinical  isolates.  The  four  main  features  examined  were  
staphyloxanthin,  a  carotenoid  pigment  and  chemical  virulence  factor  mucoidy,  an  indication  of  
ica  expression;  biofilm  formation;  and  accessory  gene  regulator  ( Agr )  function.  Carotenoid  
pigments  were  extracted  and  the  absorbance  values  were  normalized  in  comparison  to  a  known  
sample.  The  absorbance  values  of  biofilm  stained  with  crystal  violet  were  also  recorded.   Each  
isolate  was  plated  on  Congo  Red  agar  to  determine  Mucoid  vs.  Non-mucoid  phenotype.  Sheep’s  
blood  agar  was  also  used  to  test  the  presence  of  Agr  protein  with  each  isolate.   The  samples  
exhibited  a  wide  variety  of  pigmentation  levels,  while  the  majority  of  them  expressed  a  
non-mucoid  phenotype.  Comparative  analysis  revealed  that  isolates  with  the  mucoid  phenotype  
show  a  statistically  significant  (p-value  of  0.0414)  tendency  to  produce  less  carotenoids  than  the  
non-mucoid  isolates.  However,  there  were  no  statistically  significant  correlations  between  the  
other  virulence  factors.  Identifying  the  trends,  and  lack  thereof,  in  virulence  factor  expression  
paved  the  way  to  a  better  understanding  of  how  the  combination  of  these  factors  impacts  the  




 Staphylococcus  aureus  ( S.  aureus )  is  an  ubiquitous  gram-positive  bacteria  that  lives  in  a  
variety  of  environments,  including  human  microbiota.  S.  aureus  also  commonly  inhabits  
domesticated  animals,  from  housepets  to  barnyard  livestock  [1–5] .  As  an  opportunistic  pathogen,  
S.  aureus  remains  passive  until  activated  by  conditions  favorable  for  infection  initiation.  There  
are  numerous  pathways  S.  aureus  can  take  to  begin  an  infection,  which  can  progress  into  a  
plethora  of  diseases.  To  name  a  few,  S.  aureus  can  cause  pneumonia,  endocarditis,  osteomyelitis,  
bacteremia,  and  sepsis  in  humans  [4] .  The  form  of  S.  aureus  infection  a  person  is  most  likely  to  
contract  depends  on  the  opportunities  provided  to  the  bacteria.   
Certain  conditions  increase  the  likelihood  of  S.  aureus  infections.  In  hospital  settings  and  
nursing  homes,  the  higher  concentration  of  people  with  weakened  immune  systems  and  the  use  
of  intravenous  therapy  provides  an  advantage  for  S.  aureus  [6] .  The  Center  for  Disease  Control  
reports  a  decline  in  bloodstream  infections  as  sanitization  and  methods  of  intervening  
transmission  improve  [7] .  Other  communal  spaces,  such  as  gyms  and  correctional  facilities,  are  
also  conducive  to  S.  aureus  infection  initiation  [5,8,9] .  The  persistence  of  S.  aureus  in  these  
settings  is  a  cause  for  concern  due  to  the  emergence  of  antibiotic  resistant  S.  aureus .  Antibiotic  
resistance  makes  S.  aureus  a  greater  threat,  particularly  to  immunocompromised  individuals.  
The  National  Institutes  of  Health  defines  immunocompromised  as  having  a  weakened  
immune  system  and  reduced  ability  to  fight  infections.  A  person  can  become  
immunocompromised  due  to  a  diverse  array  of  circumstances:  living  with  AIDS,  cancer,  
diabetes,  malnutrition,  immunosuppressive  treatments,  and  certain  genetic  disorders  [10] .  
Immunocompromised  populations  are  particularly  vulnerable  to  opportunistic  pathogens,  
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including  S.  aureus .  Patients  with  cystic  fibrosis  form  an  immunocompromised  population  that  
the  Conlon  Lab  specifically  aims  to  help  combat  S.  aureus  infections.   
Cystic  fibrosis  is  a  disease  caused  by  loss-of-function  mutations  in  the  cystic  fibrosis  
transmembrane  conductance  regulator  (CFTR).  The  result  is  a  severe  lack  of  respiratory  system  
defenses  [11] .  S.  aureus  is  one  of  the  most  prevalent  pathogens  isolated  from  cystic  fibrosis  
patient  airways  [12] .  Early  S.  aureus  infections  are  detrimental  to  cystic  fibrosis  lungs,  paving  
the  way  for  chronic  pneumonia  [13] .  Unique  conditions  within  cystic  fibrosis  lungs  make  the  
eradication  of  S.  aureus  challenging.  A  cystic  fibrosis  lungs  mouse  model  is  currently  being  
developed  to  facilitate  testing  of  novel  treatment  plans.   
Following  the  discovery  of  penicillin,  scientists  utilized  an  assortment  of  antibiotics  to  
combat  bacterial  infections:  erythromycin,  gentamicin,  streptomycin,  vancomycin,  etc.  [14] .  
Subsequently,  there  has  been  a  notable  increase  of  methicillin-resistant  S.  aureus  (MRSA)  strains  
and  non-growing,  dormant  ‘persister’  subpopulations  exhibiting  high  levels  of  tolerance  to  
antibiotics  [15–17] .  Antibacterial  agents  need  additional  support  in  the  infection  environment  to  
successfully  eradicate  pathogens.  Variations  within  the  antagonistic  colonies  must  also  be  
considered  to  prepare  an  effective  treatment  plan.   
Deploying  the  most  effective  antimicrobial  with  precision  is  crucial  for  successful  
treatment,  but  there  are  numerous  variables  to  consider  when  designing  antimicrobial  treatments.  
For  example,  Radilinski  and  Conlon  discuss  pathogen  interaction,  microbial  interspecies  
interaction,  and  metabolic  heterogeneity  in  relation  to  persisters  and  cystic  fibrosis  patients  [18] .  
While  previous  literature  emphasizes  the  significance  of  understanding  the  human  microbiome  
and  the  interspecies  reaction  within  [19] ,  this  study  investigated  the  variable  of  intraspecies  
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diversity.  Virulence  factors  are  characteristics  that  contribute  to  S.  aureus  success  in  an  infection  
environment.  This  study  analyzed  diversity  in  virulence  factor  expression  amongst  clinical  
isolates  from  cystic  fibrosis  patients.  
The  virulence  factors  assessed  were:  pigmentation,  mucoidy,  biofilm  formation,  and  agr  
protein.  Pigmentation  encompassed  the  production  of  the  carotenoid  pigment  staphyloxanthin.  
The  chemical  staphyloxanthin  is  a  virulence  factor  believed  to  help  S.  aureus  survive  assaults  
from  reactive  oxygen  species  [21] .  Observations  of  varying  coloration  in  overnight  cultures  in  
tryptic  soy  broth  suggest  different  levels  of  carotenoid  production  between  samples.  Mucoidy  
has  been  linked  to  mutations  in  the  ica  locus,  which  is  associated  with  biofilm  formation  (12).  
Isolates  with  high  levels  of  mucoidy  tend  to  present  a  wrinkled  phenotype  on  Congo  Red  agar,  
while  low  mucoid  levels  appear  as  smooth  colonies  [12,20] .  Biofilm  formation  refers  to  S.  
aureus  colonies  creating  a  thick  membrane  that  is  difficult  for  antimicrobials  to  penetrate.  This  
survival  advantage  was  quantified  by  staining  the  membrane  with  crystal  violet  and  measuring  
absorbance  levels.  Agr  locus  functionality  indicated  the  activity  of  a  quorum  sensing  
transcriptional  unit  and  encoded  a  δ  hemolysin  which  formed  a  band  on  sheep's  blood  agar.  
Quorum  sensing  allows  individual  S.  aureus  to  estimate  the  presence  of  other  S.  aureus  as  a  
component  of  determining  if  conditions  are  favorable  for  infection.  Variation  amongst  individual  
virulence  factor  expression  was  observed  before  attempting  to  find  correlations  between  
virulence  factors.  
The  goal  of  this  study  was  to  identify  expected  correlations  in  the  virulence  factor  
expression  of  S.  aureus  isolates.  Specifically,  this  research  evaluated  the  relationship  between  
carotenoid  abundance  and  mucoidity  found  in  isolated  patient  samples  made  available  to  the  
Conlon  lab  for  study  by  UNC  Hospital  clinics.  If  a  sample  presented  the  mucoid  phenotype,  it  
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did  not  express  an  abundance  of  the  other  known  virulence  factor  indicated  by  pigmentation.  
Finding  this  inverse  correlation  in  virulence  factor  expression  within  this  set  of  samples  
contributed  to  the  Conlon  Lab’s  understanding  of  infection  site  environments.  Further  studies  
could  be  used  to  influence  novel  treatment  designs,  especially  those  tested  in  a  cystic  fibrosis  






























Collection  and  Storage  of  Samples  
 Thirty-six  S.  aureus  samples  were  isolated  from  patients  with  cystic  fibrosis.  Sample  
vials  were  stored  in  a  -80  °C  deep  freezer.  
Carotenoid  Extraction  
 Carotenoids  were  extracted  from  samples  in  triplicate  using  methanol  and  multiple  stages  
of  heating  and  centrifugation,  as  previously  described  by  Morikawa  et.  al.  [21].  To  summarize,  
1ml  of  overnight  cultures  grown  in  Tryptic  Soy  Broth  (Remel;  Lenexa,  KS)   were  pelleted  using  
a  microcentrifuge  (Thermo  Fisher  Scientific;  Waltham,  Massachusetts)  and  resuspended  in  250  
μl  methanol.  The  bacteria  were  incubated  at  55°C  for  3  minutes,  pelleted  at  10,000xg  for  3  
minutes  using  the  relative  centrifugal  force  setting,  and  the  supernatant  containing  the  extracted  
carotenoids  was  removed,  and  the  extraction  procedure  was  repeated  once.  Triplicates  of  the  
common  control  strain  LAC  carotenoids  served  as  standard  each  extraction.  The  pigmentation  of  
each  final  product  was  quantified  using  a  Synergy  H1  plate  reader  (Biotek;  Winooski,  VT)  at  a  
wavelength  of  465  nm.  To  account  for  variation  in  pigment  production,  samples  were  averaged  
and  standardized  against   LAC  (Sample  Identification  #  1145).  
Mucoid  vs.  Non-mucoid  Characterization  
 To  investigate  the  expression  of  mucoid  vs.  non-mucoid  phenotype  within  the  list  of  
isolates,  colonies  of  each  isolate  were  grown  on  Congo  red  agar.  The  Congo  red  agar  plates  
contained  brain  heart  infusion  (BHI)  agar  (Thermo  Fisher  Scientific),  3.6%  sucrose,  0.5%  
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glucose,  and  0.08%  Congo  red  (Sigma  Aldrich;  St.  Louis,  MO)  in  alignment  with  the  methods  of  
Brooks  and  Jefferson  [12].  The  plates  were  streaked  with  a  portion  of  the  S.  aureus  from  each  
isolated  sample,  and  incubated  at  37℃.  The  plates  were  examined  at  24-hour  increments  
following  initial  plating  to  assess  colony  growth.  Identification  of  the  phenotypes  would  be  
based  on  the  images  from  previous  work  characterizing  S.  aureus  samples  on  Congo  red  agar  
[12].  
Biofilm  Formation  
Triplicate  overnight  cultures  of  each  isolate  were  diluted  1:200  into  fresh  TSB.  96-well  tissue  
culture  plates  (Corning®  no.  3599)  were  inoculated  with  100μl  of  the  diluted  samples  and  
incubated  under  static  conditions  for  24  hours  at  37℃.  A  plate  washer  (Nunc™)  was  used  to  
wash  the  microtiter  plates  with  distilled  water.  The  plates  dried  for  one  hour  at  65℃.  100μl  of  
0.4%  crystal  violet  solution  was  used  to  stain  each  well  for  5  minutes,  followed  by  a  second  
round  of  plate  washing.  The  contents  of  the  wells  were  solubilized  with  100μl  of  5%  acetic  acid.  
A  BioTek®  Synergy  H1  plate  reader  quantified  the  absorbance  of  the  adhered,  stained  cells  at  a  
wavelength  of  492nm.  Isolates  with  an  average  absorbance  value  greater  than  0.1  were  
considered  biofilm  positive.  
Agr  Function  (Quorum  Sensing)  
Isolates  were  grown  on  sheep  blood  agar  (Tryptic  Soy  Agar  (TSA)  with  sheep  blood,  Thermo  
Fisher  Scientific),  which  shows  δ  hemolysis  when  S.  aureus  produces  functional  Agr  protein  
[24].  RN4220,  a  laboratory  strain  known  to  only  produce  β  hemolysin  was  inoculated  down  the  
center  of  the  sheep  blood  agar  plate.  Test  isolates  were  inoculated  perpendicular  to  RN4220  
without  making  direct  contact.  Inoculated  plates  were  then  incubated  for  16-18  hours  at  37°C,  
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followed  by  1-2  hours  at  4°C  to  promote  further  hemolysis  development.  An  “arrowhead”  
indicating  δ  hemolysis  formed  between  RN4220  and  the  test  isolates  positive  for  Agr .  The  
negative  control  was  an  agr -lacking  mutant  (HG003  agrC::erm)  and  its  agr  positive  parent  strain  
(HG003)  was  the  positive  control.  Both  controls  were  grown  on  each  sheep  blood  agar  plate  
(Thermo  Fisher  Scientific)  with  the  test  isolate  triplicates  from  independent  cultures.   
Computational  Analysis  
Logistic  regression  analysis  and   Two-Tailed  T-Tests  in  Microsoft  Excel  were  used  to  quantify  
correlations  between  virulence  factor  data.  Multiple  regression  analysis  was  performed  utilizing  












Carotenoid  Expression  Quantification  
  Since  staphyloxanthin  is  the  predominant  carotenoid  pigment  in  S.  aureus ,  quantifying  
extracted  carotenoid  pigment  levels  equates  to  determining  staphyloxanthin  abundance.  
Increased  levels  of  absorption  meant  higher  staphyloxanthin  concentration.  Only  7  of  the  36  
samples  had  an  average  absorbance  greater  than  0.1.   All  of  the  samples  had  an  average  
absorbance  less  than  0.25.  There  was  wide  variation  in  carotenoid  expression  (Figure  1).  To  
ensure  the  extraction  data  were  consistent,  all  samples  were  compared  to  the  lab  strain  USA300  
LAC  (#1145),  a  well  characterized  MRSA  isolate.   
  
Figure  1.   
Pigmentation  as  indicated  by  the  absorbance  levels  of  each  isolate  were  displayed  in  comparison  to  LAC  (sample  
identification  #  1145).  Error  bars  represent  the  standard  deviation  amongst  replicates  for  each  sample.  Absorbance  




Mucoid  Phenotype  Determination  
 Colonies  of  both  mucoid  (a)  and  non-mucoid  (b,  c)  phenotype  S.  aureus  presented  on  the  
plates  (Figure  2).  Twenty-five  of  the  36  appeared  to  be  the  non-mucoid  phenotype.  The  mucoid  
phenotype  ruffles  were  more  pronounced  in  certain  samples.  Occasionally,  apparent  mucoid  
phenotype  colonies  took  more  than  one  24-hour  increment  to  present  focal  wrinkles.  A  sample  
would  be  considered  mucoid,  if  the  colonies  appeared  to  present  a  wrinkled  phenotype  in  at  least  
two  of  the  four  trials  conducted.  
  
Figure  2.  Mucoid  vs.  Non-mucoid  Example  
Sample  #92  (a)  exhibited  the  wrinkled,  mucoid  phenotype.  Sample  #323  (b)  was  an  example  of  the  smooth,  
non-mucoid  phenotype.  Sample  #324  (c)  displayed  a  darker-hued  version  of  the  smooth,  non-mucoid  phenotype.  
Photograph  taken  after  ~72  hours  of  incubation  (Date:  Feb.  20th  2020).  
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Biofilm   Production   Quantification  
Biofilm  produced  by  each  isolate  was  stained  with  crystal  violet,  which  allowed  biofilm  
formation  to  be  quantified  by  absorbance.   Isolates  with  an  average  absorbance  less  than  0.1  
were  considered  biofilm  positive.  Half  of  the  isolates  were  recorded  as  biofilm  positive.  
  
Figure  3.   
Biofilm  production  as  indicated  by  the  average  absorbance  levels  of  each  isolate  were  displayed  in  comparison.  
Absorbance  was  recorded  at  a  wavelength  of  492  nm.  
  
Agr  FunctionDetermination  
Evaluation  of  δ  hemolysis  activity  on  sheep's  blood  agar  revealed  that  only  4  of  the  36  
samples  did  not  have  agr  function.  The  majority  was  agr  (+).  
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Figure  4.   
An  example  of  isolates  grown  on  sheep's  blood  agar  with  RN4220  to  potentially  interact  with  down  the  center.  In  the  
top  right,  the  large  band  (almost  like  two  fused  together)  was  the  positive  control  HG003.  The  top  left  band  was  the  
negative  control  HG003  agrC::erm.  The  three  bands  below  HG003  represented  triplicates  of  a  positive  isolate.  The  
remaining  bands  consisted  of  triplicates  for  two  negative  isolates.  
  
T-Test  Analysis  for  Significant  Correlations  
Two  sample  equal  variance  T-test  were  used  as  one  statistical  model  to  identify  significant  
correlations  between  virulence  factors.  Every  pair  combination  of  the  four  virulence  factors  were  
tested.  The  p-value  cutoff  was  0.05.  Pigmentation  vs.  Mucoidy  was  the  only  test  that  produced  a  
statistically  significant  p-value  of  0.0414  (Figure  5).  All  other  combinations  did  not  qualify  as  
statistically  significant.  
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Figure  5.   
Averaged  absorbance  values  for  mucoid  and.  non-mucoid  samples.  Error  bars  represent  standard  deviation.  A  two  
sample  equal  variance  T-test  was  performed  on  the  average  absorbances  of  the  non-mucoid  samples  vs.  the  mucoid  
samples.  The  p-value  is  0.0414.   
  
Logistic  Regression  for  Continuous  vs.  Binary  Virulence  Factors  
Basic  logistic  regression  analysis  was  used  as  an  additional  method  to  quantify  the  relationship  
between  virulence  factors.  Logistic  regression  required  one  continuous  variable  to  generate  
predictions  regarding  a  binary  variable.  Four  logistic  regressions  assessed  the  influence  of  the  
continuous  virulence  factors  (pigmentation  and  biofilm)  on  the  binary  virulence  factors  (mucoidy  
and  agr )  (Figure  6).  The  logistic  regressions  with  the  lowest  p-value  to  the  greatest  are  as  
follows:  pigmentation  vs.  mucoidy  (p  =  0.0548),  biofilm  vs.  mucoidy  (p  =  0.140),  pigmentation  
vs.  agr  (p  =  0.288)   biofilm  vs.  agr  (p  =  0.940).  None  of  the  resultant  p-values  were  below  
p-value  cutoff  (0.05).  
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(A)   (B)   
(C)   (D)   
Figure  6.  
Actual  values  represented  the  true  values  for  each  sample  along  with  the  calculated  logistic  
regression  line  for  pigmentation  absorbance  values  vs.  mucoidy  (A;  p-value  =  0.0548),  
pigmentation  absorbance  values  and  agr  protein  expression  (B;  p-value  =  0.288),  biofilm  
absorbance  data  and  mucoidy  (C;  p-value  =  0.140),  and  biofilm  absorbance  data  and  agr  
protein  expression  (D;  p-value  =  0.940).  
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Linear  Regression  Between  Continuous  Virulence  Factors  
To  directly  compare  pigment  and  mucoidy,  a  scatter  plot  was  generated  (Figure  7).  The  trendline  
possessed  a  low  R-squared  value  of  0.0057.  The  slope  of  the  line  indicates  a  statistically  
insignificant  negative  correlation.  
  
Figure  7  
Scatter  plot  of  pigmentation  in  standard  units  vs.  biofilm  in  standard  units.  The  trendline  and  





Multiple  Logistic  Regression  Analysis  Produced  a  Four-Variable  Model  
The  combined  pigmentation,  biofilm,  and  Agr  data  was  used  to  predict  mucoidy  in  a  
four-variable  model  with  a  favorable  distribution  (Figure  8  .iii).  A  significant  p-value  for  




(i) Pigmentation  Biofilm  Agr  
Pigmentation  1.000  -0.07574  0.1848  
Biofilm  -0.07574  1.000  0.01250  
Agr  0.1848  0.01250  1.000  
(ii)  Coefficient  SE  z-stat  Lower  z0.025  Upper  z0.975  exp(b)  p-value  
b0  1.1279  1.4453  0.7804  -1.7049  3.9608  3.0893  0.4352  





Biofilm  -7.8844  5.4375  -1.4500   -18.5417 
  
2.7730  0.0003766  0.1471  
Agr  -0.8141   1.2912  -0.6304  -3.3449  1.7167   0.4431  0.5284  
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Figure   8   
Derived  from  multiple  logistic  regression  including  all  four  virulence  factors:  (i)  Correlation  
matrix  of  the  x-values  (pigmentation,  biofilm,  and  agr),  (ii)  table  of  resulting  coefficients,  and  












The  majority  of  the  statistics  indicate  that  my  initial  hypothesis  that  S.  aureus   virulence  
factors  will  have  significant  correlation  was  not  completely  accurate.   The  lack  of  correlations  
between  the  other  virulence  factors  may  be  influenced  by  two  outliers  in  the  biofilm  data  (Figure  
7).  Additionally,  more  agr  (-)  samples  would  be  beneficial  to  counter  the  overwhelming  agr  (+).  
My  four  statistical  analysis  models  all  indicated  that  there  is  not  a  significant  relationship  
between  the  expression  of  the  virulence  factors,  except  for  pigmentation  with  respect  to  mucoidy.  
There  appears  to  be  a  correlation  between  pigmentation  and  mucoidy.  All  the  mucoid  
phenotype  samples  had  an  absorbance  of  less  than  0.1.  When  the  averages  of  the  two  types  of  
samples  were  compared,  a  significant  p-value  of  0.0414  was  produced  (Figure  5).  This  suggests  
that  the  strains  with  the  mucoid  phenotype   produce  less  carotenoids  than  the  non-mucoid  strains.  
Conducting  more  trials  with  the  same  samples  would  be  beneficial  to  verify  these  observed  
trends.  The  process  of  obtaining  the  pigmentation  and  mucoidy  results  were  limited  to  a  few  
trials  each.  As  observed  with  the  LAC  triplicates  that  accompanied  every  round  of  carotenoid  
extraction,  each  strain  has  the  potential  for  high  variability  in  pigment  production.  Certain  
colonies  appeared  to  be  an  intermediate  phenotype:  smooth  yet  with  the  presence  of  some  
wrinkles  especially  around  the  edge  of  the  colony.  The  sample  needed  distinct  wrinkles  to  be  
considered  a  mucoid  strain  and  typically  developed  within  the  following  24-hour  incubation  
period.  Generally,  colonies  appearing  intermediate  in  feature  decreased  as  incubation  time  
increased.  
Previous  literature,  particularly  work  from  Schwartbeck  [12]  and  Brooks  and  Jefferson  
[20]  involving  Congo  red  agar  plates  to  test  for  mucoidy,  does  not  mention  any  intermediate  
20  
between  the  phenotypes.  Brooks  and  Jefferson  report  the  phenotypic  identity  of  their  colonies  as  
straightforward  to  discern  [20] .  Perhaps  differences  in  the  plating  technique  or  timeline  of  colony  
analysis  account  for  the  distinction.  With  additional  trials,  varying  either  the  plating  technique  or  
the  timeline  of  analysis  could  prove  beneficial  for  the  accuracy  of  S.  aureus  phenotypic  
identification.  
Considering  that  there  is  a  suggested  correlation  between  the  carotenoid  production  and  
the  mucoidy  of  S.  aureus  samples,  further  investigation  may  reveal  patterns  involving  other  
characteristics.  One  particular  trait  that  may  be  heavily  influenced  by  mucoidy  is  the  formation  
of  biofilm.  Studies  within  The  Conlon  Lab  emphasizes  how  the  prevalence  of  biofilm  in  an  
infection  site  can  complicate  the  treatment  process  [22] .  The  efficacy  of  the  treatments  used  
against  S.  aureus  may  be  improved  by  understanding  the  relationship  between  pigmentation,  
mucoidy,  and  pigmentation.  Ideally,  if  the  pigmentation  or  the  mucoid  phenotype  indicate  the  
sample  strain’s  ability  to  produce  biofilm,  an  appropriate  response  can  be  launched  to  combat  
that  infection.  Furthermore,  The  presence  of  Pseudomonas  aeruginosa  can  affect  the  
characteristics  of  S.  aureus  in  vivo  [23] .  Perhaps,  when  with  a  better  understanding  of  S.  aureus  
characteristics  and  their  relationship  with  Pseudomonas  aeruginosa  we  can  utilize  that  
information  to  estimate  the  abundance  of   Pseudomonas  aeruginosa  as  well.  Perhaps,  more  
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Table  1.  List  of  Samples  
  
Strain  Number  Source   
BC78  Cystic  Fibrosis  Clinical  Isolate  
BC80  Cystic  Fibrosis  Clinical  Isolate  
BC92  Cystic  Fibrosis  Clinical  Isolate  
BC323  Cystic  Fibrosis  Clinical  Isolate  
BC324  Cystic  Fibrosis  Clinical  Isolate  
BC560  Cystic  Fibrosis  Clinical  Isolate  
BC629  Cystic  Fibrosis  Clinical  Isolate  
BC670  Cystic  Fibrosis  Clinical  Isolate  
BC671  Cystic  Fibrosis  Clinical  Isolate  
BC703  Cystic  Fibrosis  Clinical  Isolate  
BC780  Cystic  Fibrosis  Clinical  Isolate  
BC783  Cystic  Fibrosis  Clinical  Isolate  
BC784  Cystic  Fibrosis  Clinical  Isolate  
BC786  Cystic  Fibrosis  Clinical  Isolate  
BC787  Cystic  Fibrosis  Clinical  Isolate  
BC788  Cystic  Fibrosis  Clinical  Isolate  
BC789  Cystic  Fibrosis  Clinical  Isolate  
BC790  Cystic  Fibrosis  Clinical  Isolate  
BC796  Cystic  Fibrosis  Clinical  Isolate  







BC806  Cystic  Fibrosis  Clinical  Isolate  
BC807  Cystic  Fibrosis  Clinical  Isolate  
BC814  Cystic  Fibrosis  Clinical  Isolate  
BC816  Cystic  Fibrosis  Clinical  Isolate  
BC820  Cystic  Fibrosis  Clinical  Isolate  
BC821  Cystic  Fibrosis  Clinical  Isolate  
BC822  Cystic  Fibrosis  Clinical  Isolate  
BC823  Cystic  Fibrosis  Clinical  Isolate  
BC824  Cystic  Fibrosis  Clinical  Isolate  
BC825  Cystic  Fibrosis  Clinical  Isolate  
BC836  Cystic  Fibrosis  Clinical  Isolate  
BC857  Cystic  Fibrosis  Clinical  Isolate  
BC864  Cystic  Fibrosis  Clinical  Isolate  
BC883  Cystic  Fibrosis  Clinical  Isolate  
BC925  Cystic  Fibrosis  Clinical  Isolate  
BC952  Cystic  Fibrosis  Clinical  Isolate  
BC1145 Lab  strain  USA  300  LAC  
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